Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dermatomyositis and malignancy.

J B Richardson1, J P Callen

  • 1Department of Medicine, University of Louisville School of Medicine, Kentucky.

The Medical Clinics of North America
|September 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Soil Lead Risks Associated With Urbanization Histories in Springfield MA and Hartford CT, USA.

GeoHealth·2026
Same author

Ergot in Purpura Hemorrhagia.

Atlanta medical and surgical journal·2022
Same author

Synthesis of earthworm trace metal uptake and bioaccumulation data: Role of soil concentration, earthworm ecophysiology, and experimental design.

Environmental pollution (Barking, Essex : 1987)·2020
Same author

Trace Elements in Surface Soils and Megascolecidae Earthworms in Urban Forests Within Four Land-Uses Around Poughkeepsie, New York, USA.

Bulletin of environmental contamination and toxicology·2019
Same author

Impact of human platelet lysate on the expansion and chondrogenic capacity of cultured human chondrocytes for cartilage cell therapy.

European cells & materials·2018
Same author

Exotic Earthworms Decrease Cd, Hg, and Pb Pools in Upland Forest Soils of Vermont and New Hampshire USA.

Bulletin of environmental contamination and toxicology·2017
Same journal

Care Transitions Continue to Evolve.

The Medical clinics of North America·2026
Same journal

Navigating the Gaps: A Comprehensive Overview of Care Transitions Across the Continuum.

The Medical clinics of North America·2026
Same journal

Care Transitions and Value-Based Payment Models in the United States.

The Medical clinics of North America·2026
Same journal

Technology and Innovation in Care Transitions: Imagining the Future of Postdischarge Care.

The Medical clinics of North America·2026
Same journal

Primary Care, Specialists, and Hospitals: Bridging the Gaps in Communication and Coordination.

The Medical clinics of North America·2026
Same journal

Social Determinants of Health: Unique Considerations in Transitions of Care.

The Medical clinics of North America·2026
See all related articles

Dermatomyositis likely increases cancer risk, with tumor types mirroring general populations. Malignancy can appear before, during, or after dermatomyositis diagnosis, potentially sharing immune-related causes.

Area of Science:

  • Rheumatology
  • Oncology
  • Dermatology

Background:

  • Dermatomyositis is an idiopathic inflammatory myopathy.
  • A potential association between dermatomyositis and malignancy has been long suspected.

Purpose of the Study:

  • To summarize the relationship between dermatomyositis and malignancy.
  • To guide the search for malignancy in dermatomyositis patients.

Main Methods:

  • Review of existing literature and clinical observations.
  • Analysis of tumor types and their incidence in dermatomyositis patients.

Main Results:

  • Dermatomyositis is probably associated with an increased incidence of malignancy.
  • Tumor types in dermatomyositis patients approximate general population frequencies.

Related Experiment Videos

  • Malignancy can precede, coincide with, or follow dermatomyositis diagnosis.

    • Conclusions:

    • Dermatomyositis and malignancy may share a common pathogenesis involving abnormal immune function.
    • Malignancy screening in dermatomyositis patients should be based on clinical findings and laboratory tests.
    • Treatment of associated malignancy may not always impact the course of dermatomyositis.